How many institutions held FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in Q3 2023?

30 institutional investors reported FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share for Q3 2023. Use the holders table for investor-level position and value details.

Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)

Q: What does CUSIP 34962G109 represent in this 13F holders report?

CUSIP 34962G109 is the security identifier for FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 34962G109

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 20,563,488
Total 13F shares: 16,699,691
Share change: +13,235,698
Total reported value: $11,053,360
Put/Call ratio: 0.34%
Price per share: $0.66
Number of holders: 30
Value change: +$8,677,955
Number of buys: 14
Number of sells: 12

Quarterly Holders Quick Answers

What is CUSIP 34962G109?
CUSIP 34962G109 identifies FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2023
Previous quarter: Q2 2023

Recent filing periods for CUSIP 34962G109:

Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022

Top shareholders of FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BML Capital Management, LLC	13F	Company	8.4%	1,735,075	$1,804,478	—	30 Jun 2023	13F
VANGUARD GROUP INC	13F	Company	3.2%	664,830	$691,423	—	30 Jun 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1%	204,800	$213,000	—	30 Jun 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.94%	193,333	$201,066	—	30 Jun 2023	13F
BlackRock Finance, Inc.	13F	Company	0.89%	182,326	$189,619	—	30 Jun 2023	13F
Old Well Partners, LLC	13F	Company	0.33%	68,600	$71,344	—	30 Jun 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.28%	57,864	$60,179	—	30 Jun 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.28%	57,591	$59,895	—	30 Jun 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.28%	57,102	$59,386	—	30 Jun 2023	13F
STATE STREET CORP	13F	Company	0.2%	41,664	$43,331	—	30 Jun 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.18%	36,865	$38,340	—	30 Jun 2023	13F
NORTHERN TRUST CORP	13F	Company	0.16%	33,632	$34,977	—	30 Jun 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.15%	30,319	$31,532	—	30 Jun 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.11%	22,505	$23,405	—	30 Jun 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.1%	20,819	$21,652	—	30 Jun 2023	13F
GROUP ONE TRADING LLC	13F	Company	0.08%	16,347	$17,001	—	30 Jun 2023	13F
Aries Wealth Management	13F	Company	0.06%	13,000	$13,520	—	30 Jun 2023	13F
HSBC HOLDINGS PLC	13F	Company	0.05%	10,745	$10,852	—	30 Jun 2023	13F
FNY Investment Advisers, LLC	13F	Company	0.05%	9,564	$9,000	—	30 Jun 2023	13F
Cutler Group LLC / CA	13F	Company	0.02%	3,987	$4,000	—	30 Jun 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	0.01%	1,080	$1,123	—	30 Jun 2023	13F
MORGAN STANLEY	13F	Company	0%	994	$1,034	—	30 Jun 2023	13F
SIMPLEX TRADING, LLC	13F	Company	0.01%	1,346	$1,000	—	30 Jun 2023	13F
Russell Investments Group, Ltd.	13F	Company	0%	453	$471	—	30 Jun 2023	13F
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA	13F	Company	0%	193	$201	—	30 Jun 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	138	$144	—	30 Jun 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	117	$122	—	30 Jun 2023	13F
UBS Group AG	13F	Company	0%	33	$34	—	30 Jun 2023	13F
JPMORGAN CHASE & CO	13F	Company	0%	17	$18	—	30 Jun 2023	13F
Patricia S. Walker	3/4/5	Director	— class O/S missing	25,000	—	—	01 Jun 2022	3/4/5

Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) as of Q3 2023

As of 30 Sep 2023, Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,699,691 shares. The largest 10 holders included TYBOURNE CAPITAL MANAGEMENT (HK) LTD, PERCEPTIVE ADVISORS LLC, BVF INC/IL, FRED ALGER MANAGEMENT, LLC, FARALLON CAPITAL MANAGEMENT LLC, BML Capital Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., and RENAISSANCE TECHNOLOGIES LLC. This page lists 30 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 Value $	Q3 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.